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BACKGROUND AND PURPOSE: As numerous questions remain about the best anesthetic strategy during 
thrombectomy, we 
assessed functional and radiological outcomes in stroke patients treated with thrombectomy in presence of 
general 
anesthesia (GA) versus conscious sedation (CS) and local anesthesia (LA). 
METHODS: We conducted a cohort study on prospectively collected data from 4429 patients enrolled in the 
Italian Registry of 
Endovascular Treatment in Acute Stroke. 
RESULTS: GA was used in 2013 patients, CS in 1285 patients, and LA in 1131 patients. The rates of 3-month 
modified 
Rankin Scale score of 0–1 were 32.7%, 33.7%, and 38.1% in the GA, CS, and LA groups: GA versus CS: odds 
ratios after 
adjustment for unbalanced variables (adjusted odds ratio [aOR]), 0.811 (95% CI, 0.602–1.091); and GA 
versus LA: aOR, 
0.714 (95% CI, 0.515–0.990). The rates of modified Rankin Scale score of 0–2 were 42.5%, 46.6%, and 52.4% 
in the GA, 
CS, and LA groups: GA versus CS: aOR, 0.902 (95% CI, 0.689–1.180); and GA versus LA: aOR, 0.769 (95% CI, 
0.566– 
0.998). The rates of 3-month death were 21.5%, 19.7%, and 14.8% in the GA, CS, and LA groups: GA versus 
CS: aOR, 
0.872 (95% CI, 0.644–1.181); and GA versus LA: aOR, 1.235 (95% CI, 0.844–1.807). The rates of parenchymal 
hematoma 
were 9%, 12.6%, and 11.3% in the GA, CS, and LA groups: GA versus CS: aOR, 0.380 (95% CI, 0.262–0.551); 
and GA 
versus LA: aOR, 0.532 (95% CI, 0.337–0.838). After model of adjustment for predefined variables (age, sex, 
thrombolysis, 
National Institutes of Health Stroke Scale, onset-to-groin time, anterior large vessel occlusion, procedure 
time, prestroke 
modified Rankin Scale score of <1, antiplatelet, and anticoagulant), differences were found also between 
GA versus CS as 
regards modified Rankin Scale score of 0–2 (aOR, 0.659 [95% CI, 0.538–0.807]) and GA versus LA as regards 
death (aOR, 
1.413 [95% CI, 1.095–1.823]). 
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CONCLUSIONS: GA during thrombectomy was associated with worse 3-month functional outcomes, 
especially when compared 
with LA. The inclusion of an LA arm in future randomized clinical trials of anesthesia strategy is 
recommended. 
Key Words: anesthesia ◼ conscious sedation ◼ groin ◼ odds ratio ◼ thrombectomy 
Mechanical thrombectomy for ischemic stroke with 
large vessel occlusion substantially reduces disability, with 5 randomized clinical trials leading 
to guideline changes worldwide.1–5 However, numerous 
questions remain about the best practices for mechanical thrombectomy, including which anesthetic 
strategy 
results in the best clinical outcomes. 
Two previous meta-analyses reported worse 3-month 
functional outcomes from general anesthesia (GA) than 
from nongeneral anesthesia (non-GA; composite of conscious sedation [CS] and local anesthesia [LA]) 
during 
mechanical thrombectomy,6,7 while the rates of recanalization success and symptomatic intracerebral 
hemorrhage (sICH) did not differ.6,7 
In the last years, the interest has focused on the comparison between GA and CS during mechanical 
thrombectomy. CS is often considered as the ideal compromise 
during mechanical thrombectomy by preserving patient 
cooperation, comfort, and procedural speed compared with 
LA and reducing medication levels compared with GA. A 
recent meta-analysis reported that CS was associated with 
better 3-month functional outcome when compared with 
GA, while recanalization success and sICH were similar.8 
Similarly, a DEFUSE 3 (Endovascular Therapy Following 
Imaging Evaluation for Ischemic Stroke) analysis showed 
that patients who underwent thrombectomy with CS in the 
extended time window experienced a higher likelihood of 
3-month functional independence when compared with 
those who had GA.9 However, recently published randomized clinical trials (ie, SIESTA [Sedation vs 
Intubation for 
Endovascular Stroke Treatment], ANSTROKE [Anesthesia During Stroke], and GOLIATH [General or Local 
Anesthesia in Intra-Arterial Therapy])10–12 comparing GA and 
CS during mechanical thrombectomy have not confirmed 
the superiority of CS over GA. 
On the other hand, a recently published study reported 
that CS was associated with poor functional outcome 
compared with LA.13 A few studies have also compared 
the functional outcome between patients treated with 
LA and GA. A multicenter retrospective registry study 
demonstrated that clinical outcomes and survival were 
significantly better in patients treated with LA than with 
GA.14 Similarly, data from The Interventional Management of Stroke III trial showed that GA was 
associated 
with worse neurological outcomes and increased mortality compared with LA.15 Recanalization success 
and 
sICH were similar between the 2 groups. However, the 
studies were limited by sample size. 
The aim of this study was to assess functional and 
radiological outcomes in a large cohort of large vessel 
occlusion–related acute ischemic strokes treated with 
mechanical thrombectomy in presence of GA versus 
non-GA, GA versus CS, and GA versus LA. 
METHODS 
Study Design, Participants, and Procedures 
We conducted a cohort study on prospectively collected 
data of patients enrolled in the IRETAS (Italian Registry of 
Endovascular Treatment in Acute Stroke). The IRETAS is a 
multicenter, observational internet-based registry (Table I in 
the Data Supplement). Acute ischemic stroke patients with 
large vessel occlusion who received endovascular procedures 
between January 2011 and December 2017 were included 
in the present study. Participating centers were required to 
accept the rules of the IRETAS, including consecutive registration of all stroke patients receiving 
endovascular procedures 
irrespective of whether treatment was according to guidelines. 
Our analysis was conducted according to the STROBE criteria (Strengthening the Reporting of Observational 
Studies in 
Epidemiology) for observational studies.16 
Data Collection 
The clinical data were collected by neurologists, whereas the 
radiological data were collected by neuroradiologists of each 
center. Data collection is provided in the Supplementary Material 
in the Data Supplement. The choice of type of anesthesia (ie, 
GA, CS, LA) and anesthetic agents (ie, type, dosage) was at the 
discretion of the stroke team (neurologist, neuroradiologist, and 
anesthesiologist) of each center according to the particular neurological and general conditions of the 
patient (eg, prehospital 
tracheal intubation, level of consciousness, aphasia, neglect, dysphagia, agitation, aspiration, vomiting, 
respiratory failure) and the 
habits/experience of the individual operator. GA was provided 
for tracheal intubation and mechanical ventilation and was maintained according to local standards and 
protocols. CS had the 
goal of reducing agitation, anxiety, and movements, but allowing 
communication with the patient, and was performed according to 
local standards and protocols. LA was achieved by subcutaneous 
injection of anesthetic at the puncture site. 
Inclusion and Exclusion Criteria 
We included all patients with age ≥18 years who received 
mechanical thrombectomy. We excluded patients who received 
intra-arterial fibrinolysis alone and patients for lacking data on 
type of anesthesia. 
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Outcome 
The functional outcomes were (1) excellent functional outcome 
(modified Rankin Scale score of 0–1), (2) favorable functional 
outcome (modified Rankin Scale score of 0–2), and (3) death 
at 3 months. The radiological outcomes were (1) successful 
recanalization (Thrombolysis in Cerebral Infarction grading 
system 2b/3), (2) complete recanalization (Thrombolysis in 
Cerebral Infarction grading system 3) after the procedure, (3) 
any type of intracerebral hemorrhage (ICH), (4) hemorrhagic 
infarct (HI), (5) parenchymal hematoma (PH), (6) subarachnoid 
hemorrhage, and (7) sICH (defined as PH with increase of ≥4 
National Institutes of Health Stroke Scale score points from 
baseline or death) within 24 hours. 
Statistical Analysis 
We performed statistical analyses using SPSS 22.0 statistical package. Continuous variables were reported 
as median 
and interquartile range values. Proportions were calculated for 
categorical variables, dividing the number of events by the total 
number excluding missing/unknown cases. Statistical significance was established at 2-tailed 0.05 level 
(P<0.05). 
We estimated the associations of GA (versus non-GA, versus CS, and versus LA) on outcome measures by 
calculating 
the odds ratios (ORs) with 2-sided 95% CI after adjustment for 
group differences in baseline characteristics (probability value 
<0.10), including variables with a number of missing values 
which was less than one-third of the entire cohort. 
Propensity score matching of 2 similar groups (GA versus non-GA) was conducted with 1:1 ratio and match 
tolerance of 0.0005. Five models of propensity score matching 
were applied to the 2 groups of patients among the cohorts of 
patients with complete date for 3-month modified Rankin Scale 
score, Thrombolysis in Cerebral Infarction grading system, ICH, 
and sICH. The clinical and radiological predictors of the models were identified by 3 neurologists with 
clinical expertise in 
the management of stroke according to recent literature.17–20 
Predictors with a number of missing values which was greater 
than one-third of the entire cohort were excluded. The first 
Figure. Flow diagram of included and excluded patients. IA indicates intra-arterial; ICH, intracerebral 
hemorrhage; IRETAS, Italian Registry of 
Endovascular Treatment in Acute Stroke; mRS, modified Rankin Scale; and TICI, Thrombolysis in Cerebral 
Infarction. 
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(n=1131) P Value 
Demographics 
Age (y), median (IQR) 72 (59–79) 74 (63–81) 73 (62–80) <0.001 
Age (y) <0.001 
 18–49, n (%) 242 (12) 115 (8.9) 102 (9) 
 50–64, n (%) 480 (23.8) 271 (21.1) 234 (20.7) 
 65–79, n (%) 928 (46.1) 569 (44.3) 524 (46.3) 
 ≥80, n (%) 363 (18) 330 (26.7) 271 (24) 
Male sex, n (%) 1107 (55) 606 (47.2) 528 (46.7) <0.001 
Years 
2016–2017, n (%) 1017 (50.5) 811 (63.1) 626 (55.3) <0.001 
Medical history 
Hypertension, n (%) 1086 (65.8) [362] 698 (65.3) [216] 658 (63.1) [89] 0.361 
Diabetes mellitus, n (%) 302 (18.3) [362] 167 (15.6) [216] 172 (16.5) [89] 0.169 
Hyperlipidemia, n (%) 481 (29.1) [362] 264 (24.7) [216] 247 (23.7) [89] 0.003 
Current or past smoking, n (%) 373 (22.6) [362] 203 (19) [216] 209 (20.1) [89] 0.059 
Previous stroke/TIA, n (%) 101 (6.1) [362] 61 (5.7) [216] 51 (4.9) [89] 0.408 
Atrial fibrillation, n (%) 445 (27) [362] 358 (33.5) [216] 352 (33.8) [89] <0.001 
Coronary heart disease, n (%) 144 (8.7) [362] 123 (11.5) [216] 115 (11) [89] 0.034 
Congestive heart failure, n (%) 125 (7.6) [362] 82 (7.7) [216] 60 (5.8) [89] 0.140 
Antiplatelet, n (%) 531 (26.4) 368 (28.6) 361 (31.9) 0.004 
Oral anticoagulant n (%) 179 (8.9) 134 (10.4) 125 (11.1) 0.112 
Statin, n (%) 296 (14.7) 174 (13.5) 188 (16.6) 0.101 
Baseline data 
Prestroke mRS score of ≤1, n (%) 1376 (87.4) [438] 958 (86.3) [175] 903 (90.3) [131] 0.015 
NIHSS score, median (IQR) 19 (15–22) [181] 18 (14–21) [32] 16 (12–20) [5] <0.001 
NIHSS score <0.001 
 ≤10, n (%) 226 (12.3) [181] 202 (16.1) [32] 245 (21.8) [5] 
 11–15, n (%) 331 (18.1) [181] 268 (21.4) [32] 269 (23.9) [5] 
 16–20, n (%) 645 (35.2) [181] 444 (35.4) [32] 349 (31) [5] 
 >20, n (%) 630 (34.4) [181] 339 (27.1) [32] 263 (23.4) [5] 
ASPECTS, median (IQR) 10 (8–10) [644] 10 (9–10) [189] 10 (9–10) [150] <0.001 
ASPECT score of ≥6, n (%) 1285 (93.9) [644] 1057 (96.4) [189] 963 (98.2) [150] <0.001 
Occlusion site <0.001 
 Tandem, n (%) 261 (13.1) [25] 172 (13.4) [2] 159 (14.1) [3] 
 Intracranial ICA, n (%) 410 (20.6) [25] 245 (19.1) [2] 171 (15.2) [3] 
 M1-segment MCA, n (%) 724 (36.4) [25] 598 (46.6) [2] 559 (49.6) [3] 
 M2-segment MCA, n (%) 152 (7.6) [25] 171 (13.3) [2] 170 (15.1) [3] 
 Vertebrobasilar arteries, n (%) 441 (22.2) [25] 97 (7.6) [2] 69 (6.1) [3] 
Good collateral circulation, n (%) 569 (64.8) [1135] 326 (62.7) [765] 327 (75.3) [697] <0.001 
IV thrombolysis, n (%) 952 (47.4) [4] 678 (52.9) [4] 581 (51.5) [2] 0.004 
Onset-to-groin time (min), median (IQR) 240 (185–300) [130] 220 (170–289) [89] 235 (180–300) [88] <0.001 
Onset-to-groin time <0.001 
 ≤180 min, n (%) 412 (21.9) [130] 356 (29.8) [89] 248 (23.8) [88] 
 181–360 min, n (%) 1183 (62.8) [130] 707 (59.1) [89] 686 (65.8) [88] 
 6–16 h, n (%) 269 (14.3) [130] 126 (10.5) [89] 95 (9.1) [88] 
 16–24 h, n (%) 19 (1) [130] 7 (0.6) [89] 14 (1.3) [88] 
(Continued ) 
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model included age (18–49, 50–64, 65–79, or ≥80 years), sex, 
National Institutes of Health Stroke Scale score (≤10, 11–15, 
16–20, or >20), intravenous thrombolysis, and onset-to-groin 
time (≤180, 181–360, or >360 minutes). The second included 
variables of the first model plus large vessel occlusion in the 
anterior circulation and procedure time (≤60 or >60 minutes). 
The third model included variables of the second model plus 
prestroke modified Rankin Scale score of <1, antiplatelet, 
and oral anticoagulant. The fourth model included variables of 
the third model plus side of occlusion and ASPECTS (Alberta 
Stroke Program Early CT Score) of ≥6. The fifth model included 
variables of the fourth model plus additional intra-arterial fibrinolysis and single thrombectomy device 
pass. 
We calculated the ORs (95% CI) of GA (versus CS and 
versus LA) for each outcome measure after the application of 
5 models of adjustment including the same predefined variables of the 5 models of propensity score 
matching used for 
GA versus non-GA. 
Standard Protocol Approvals, Registrations, and 
Patient Consents 
Need for ethical approval or patient consent for participation 
in the IRETAS varied among participating hospitals. Ethical 
approval and informed consent were obtained when required. 
Data Availability Statement 
Anonymized data will be shared by request from any qualified 
investigator. 
RESULTS 
Among 5559 patients registered in the IRETAS cohort 
by 44 centers (Table II in the Data Supplement), 4429 
patients (n=2013, GA; n=2416, non-GA) were included 
in the study. Flow diagram of patient inclusion and exclusion is provided in the Figure. The clinical 
characteristics of the GA (n=1881, GA started before procedure; 
n=132, GA started during procedure after conversion 
from CS or LA), CS (n=1285), and LA (n=1131) groups 
are provided in Table 1. 
Unbalanced variables between GA and non-GA 
groups are provided in Table III in the Data Supplement. 
After adjustment for unbalanced variables (age, sex, 
years 2016–2017, diabetes mellitus, hyperlipidemia, current or past smoking, atrial fibrillation, coronary 
heart disease, antiplatelet, oral anticoagulant, National Institutes 
of Health Stroke Scale score, ASPECTS, occlusion site, 
intravenous thrombolysis, onset-to-groin time, type of procedure, single thrombectomy device pass, and 
procedure 
time), a significant difference was found between GA and 
non-GA groups as regards excellent functional outcome 
(32.7% versus 35.8%; adjusted OR (aOR), 0.761 [95% 
CI, 0.597–0.970]), favorable functional outcome (42.5% 
versus 49.4%; aOR, 0.799 [95% CI, 0.640–0.996]), any 
ICH (22.1% versus 28.4%; aOR, 0.584 [95% CI, 0.468– 
0.729]), HI (11.7% versus 16%; aOR, 0.736 [95% CI, 
Type of procedure <0.001 
 Aspiration alone, n (%) 611 (47.5) [727] 454 (47.4) [328] 320 (34.4) [201] 
 Stent retriever alone, n (%) 443 (34.4) [727] 322 (33.6) [328] 476 (51.2) [201] 
 Combination of aspiration and stent retriever, n (%) 232 (18) [727] 181 (18.9) [328] 134 (14.4) [201] 
Additional IA fibrinolysis, n (%) 181 (9) 89 (6.9) 142 (12.6) <0.001 
Single thrombectomy device pass, n (%) 579 (48.9) [830] 481 (53.1) [380] 508 (58.7) [266] <0.001 
Procedure time (min), median (IQR) 75 (50–109) [60] 65 (44–96) [24] 70 (45–105) [1] <0.001 
Procedure time (min) ≤60, n (%) 740 (37.9) [60] 599 (47.5) [24] 490 (43.4) [1] <0.001 
Functional outcome measures 
mRS score of 0–1, n (%) 617 (32.7) [124] 404 (33.7) [86] 416 (38.1) [39] 0.009 
mRS score of 0–2, n (%) 803 (42.5) [124] 559 (46.6) [86] 572 (52.4) [39] <0.001 
Death, n (%) 406 (21.5) [124] 236 (19.7) [86] 162 (14.8) [39] <0.001 
Radiological outcome measures 
TICI 3, n (%) 860 (43.1) [18] 572 (44.9) [12] 448 (39.8) [6] 0.038 
TICI 2b/3, n (%) 1509 (75.6) [18] 934 (73.4) [12] 883 (78.5) [6] 0.014 
Any ICH, n (%) 398 (22.1) [212] 341 (27.3) [37] 328 (29.5) [20] <0.001 
HI, n (%) 210 (11.7) [212] 180 (14.4) [37] 198 (17.8) [20] <0.001 
PH, n (%) 162 (9) [212] 157 (12.6) [37] 125 (11.3) [20] 0.005 
SAH, n (%) 68 (3.8) [212] 25 (2) [37] 29 (2.6) [20] 0.013 
sICH, n (%) 37 (2.2) [344] 26 (2.2) [77] 36 (3.3) [35] 0.140 
ASPECTS indicates Alberta Stroke Program Early CT Score; HI, hemorrhagic infarct; IA, intra-arterial; ICA, 
internal carotid artery; ICH, 
intracerebral hemorrhage; IQR, interquartile range; IV, intravenous; MCA, middle cerebral artery; mRS, 
modified Rankin Scale; NIHSS, National 
Institutes of Health Stroke Scale; SAH, subarachnoid hemorrhage; sICH, symptomatic intracerebral 
hemorrhage; TIA, transient ischemic attack; and 
TICI, Thrombolysis in Cerebral Infarction. 
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0.566–0.957]), and PH (9% versus 12%; aOR, 0.484 
[95% CI, 0.355–0.659]) (Table IV in the Data Supplement). 
Outcome measures in GA and non-GA groups after 
the application of the 5 models of propensity score are 
summarized in Table V in the Data Supplement. GA (versus non-GA) group had a higher rate of death 
according 
to the first model (20.5% versus 17.3%, P=0.028) (Table 
VI in the Data Supplement); lower rates of any ICH, HI, 
and PH according to the first (22.4% versus 30.7%, 
P<0.001; 12% versus 17.4%, P<0.001; 9.2% versus 
12.8%, P=0.003), the second (24.4% versus 30.6%, 
P=0.001; 13.8% versus 17.6%, P=0.008; 9.8% versus 
12.6%, P=0.032), and the fourth (23.6% versus 33.1%, 
P<0.001; 14.2% versus 20.6%, P=0.002; 8.3% versus 
12.6%, P=0.010) models (Tables VI, VII, and VIII in the 
Data Supplement); lower rates of excellent and favorable 
functional outcome according to the third (28.4% versus 
33.1%, P=0.030; 40.1% versus 47.2%, P=0.002) and 
the fourth (27.7% versus 33.2%, P=0.026; 40.7% versus 
46.8%, P=0.020) models (Tables VIII and IX in the Data 
Supplement); a lower rate of favorable functional outcome according to the fifth model (40.8% versus 
50.8%, 
P=0.028) (Table X in the Data Supplement); a lower rate 
of any ICH according to the third (24.4% versus 29.3%, 
P=0.018) and the fifth (22.5% versus 30.3%; P=0.049) 
models (Tables IX and X in the Data Supplement); and a 
lower rate of HI according to the fifth model (12.7% versus 21%; P=0.015) (Table X in the Data Supplement). 
After excluding 132 patients who started GA during 
the procedure, associations between GA (versus non-GA) 
and outcome measures after adjustment for unbalanced 
variables are provided in Table XI in the Data Supplement. 
Associations between GA (versus non-GA) and outcome 
measures after 5 models of adjustment for predefined 
variables are provided in Table XII in the Data Supplement. 
Unbalanced variables between GA and CS groups 
are provided in Table XIII in the Data Supplement. 
Unbalanced variables between GA and LA groups are 
provided in Table XIV in the Data Supplement. Associations between GA (versus CS and LA) and outcome 
measures after adjustment for unbalanced variables 
are provided in Table 2. A significant difference was 
found between GA and CS groups as regards any ICH 
(22.1% versus 27.3%; aORs, 0.591 [95% CI, 0.452– 
0.773]) and PH (9% versus 12.6%; aORs, 0.380 [95% 
CI, 0.262–0.551]). A significant difference was found 
between GA and LA groups as regards excellent functional outcome (32.7% versus 38.1%; aOR, 0.714 
[95% CI, 0.515–0.990]), favorable functional outcome 
(42.5% versus 52.4%; aOR, 0.769 [95% CI, 0.566– 
0.998]), any ICH (22.1% versus 29.5%; aOR, 0.539 
[95% CI, 0.398–0.730]), HI (11.7% versus 17.8%; 
aOR, 0.561 [95% CI, 0.395–0.797]), and PH (9% versus 11.3%; aOR, 0.532 [95% CI, 0.337–0.838]). 
Associations between GA (versus CS and LA) and 
outcome measures after 5 models of adjustment for 
predefined variables are provided in Table 3. A significant 
difference was found between GA and CS groups as 
regards HI (11.7% versus 14.4%) according to the first 
(aOR, 0.778 [95% CI, 0.620–0.978]) and the fifth (aOR, 
0.691 [95% CI, 0.500–0.593]) models and favorable 
Table 2. Associations of General Anesthesia (Versus 
Conscious Sedation and Local Anesthesia) With Outcome 
Measures After Adjustment for the Unbalanced Variables 
N (%) OR (95% CI) 
mRS score of 0–1 
GA vs CS 617 (32.7) 404 (33.7) 0.811 (0.602–1.091) 
GA vs LA 617 (32.7) 416 (38.1) 0.714 (0.515–0.990)* 
mRS score of 0–2 
GA vs CS 803 (42.5) 559 (46.6) 0.902 (0.689–1.180) 
GA vs LA 803 (42.5) 572 (52.4) 0.769 (0.566–0.998)* 
Death 
GA vs CS 406 (21.5) 236 (19.7) 0.872 (0.644–1.181) 
GA vs LA 406 (21.5) 162 (14.8) 1.235 (0.844–1.807) 
TICI 3 
GA vs CS 860 (43.1) 572 (44.9) 1.094 (0.855–1.399) 
GA vs LA 860 (43.1) 448 (39.8) 0.741 (0.557–1.101) 
TICI 2b/3 
GA vs CS 1509 (75.6) 934 (73.4) 1.273 (0.963–1.983) 
GA vs LA 1509 (75.6) 883 (78.5) 0.929 (0.670–1.287) 
Any ICH 
GA vs CS 398 (22.1) 341 (27.3) 0.591 (0.452–0.773)* 
GA vs LA 398 (22.1) 328 (29.5) 0.539 (0.398–0.730)* 
HI 
GA vs CS 210 (11.7) 180 (14.4) 0.867 (0.627–1.200) 
GA vs LA 210 (11.7) 198 (17.8) 0.561 (0.395–0.797)* 
PH 
GA vs CS 162 (9) 157 (12.6) 0.380 (0.262–0.551)* 
GA vs LA 162 (9) 125 (11.3) 0.532 (0.337–0.838)* 
SAH 
GA vs CS 68 (3.8) 25 (2) 2.230 (0.901–4.932) 
GA vs LA 68 (3.8) 29 (2.6) 1.158 (0.548–2.445) 
sICH 
GA vs CS 37 (2.2) 26 (2.2) 0.661 (0.321–1.363) 
GA vs LA 37 (2.2) 36 (3.3) 0.548 (0.246–1.220) 
ORs of GA (vs CS) were adjusted for the following unbalanced variables: age, 
sex, years 2016–2017, diabetes mellitus, hyperlipidemia, current or past smoking, 
atrial fibrillation, coronary heart disease, NIHSS score, ASPECTS, occlusion 
site, intravenous thrombolysis, onset-to-groin time, additional intra-arterial 
fibrinolysis, single thrombectomy device pass, and procedure time. ORs of GA 
(vs LA) were adjusted for the following unbalanced variables: age, sex, years 
2016–2017, hyperlipidemia, atrial fibrillation, coronary heart disease, congestive 
heart failure, antiplatelet, oral anticoagulant, prestroke mRS score of ≤1, NIHSS 
score, ASPECTS, occlusion site, intravenous thrombolysis, onset-to-groin time, 
type of procedure, additional intra-arterial fibrinolysis, single thrombectomy 
device pass, and procedure time. ASPECTS indicates Alberta Stroke Program 
Early CT Score; CS, conscious sedation; GA, general anesthesia; HI, hemorrhagic 
infarct; ICH, intracerebral hemorrhage; LA, local anesthesia; NIHSS, National 
Institutes of Health Stroke Scale; OR, odds ratio; PH, parenchymal hematoma; 
SAH, subarachnoid hemorrhage; sICH, symptomatic intracerebral hemorrhage; 
and TICI, Thrombolysis in Cerebral Infarction. 
*Statistical significance was established at 2-tailed 0.05 level (P<0.05). 
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functional outcome (42.5% versus 46.6%) according 
to the third (aOR, 0.768 [95% CI, 0.631–0.935]), the 
fourth (aOR, 0.800 [95% CI, 0.642–0.992]), and the 
fifth (aOR, 0.732 [95% CI, 0.556–0.962]) models. A 
significant difference was found between GA and LA 
groups as regards death (21.5% versus 14.8%) according to the first (aOR, 1.347 [95% CI, 1.075–1.686]), the 
second (aOR, 1.301 [95% CI, 1.032–1.641]), the third 
(aOR, 1.413 [95% CI, 1.095–1.823]), and the fourth 
(aOR, 1.331 [95% CI, 1.005–1.762]) models. All models 
confirmed a significant difference between GA and CS 
groups as regards any ICH and PH. All models confirmed 
a significant difference between GA and LA groups as 
regards favorable functional outcome, any ICH, and HI. A 
significant difference was confirmed between GA and LA 
groups as regards excellent functional outcome according to the third, the fourth, and the fifth models, and 
with 
PH according to the first, the fourth, and the fifth models. 
DISCUSSION 
Our study showed that GA (versus non-GA) during 
mechanical thrombectomy was significantly associated with lower rates of excellent and favorable 
functional outcome, any ICH, HI, and PH after adjustment 
Table 3. Associations of General Anesthesia (Versus Conscious Sedation and Local Anesthesia) With 
Outcome Measures 
After Adjustment for Predefined Variables Including in the 5 Models 
N (%) Model 1 OR (95% CI) Model 2 OR (95% CI) Model 3 OR (95% CI) Model 4 OR (95% CI) Model 5 OR 
(95% CI) 
mRS score of 0–1 
GA vs CS 617 (32.7) 404 (33.7) 1.056 (0.886–1.259) 1.108 (0.921–1.332) 0.818 (0.664–1.009) 0.862 (0.679–
1.094) 0.777 (0.574–1.051) 
GA vs LA 617 (32.7) 416 (38.1) 0.935 (0.781–1.119) 0.960 (0.795–1.159) 0.755 (0.611–0.934)* 0.702 (0.553–
0.890)* 0.706 (0.521–0.958)* 
mRS score of 0–2 
GA vs CS 803 (42.5) 559 (46.6) 0.912 (0.771–1.078) 0.956 (0.802–1.140) 0.768 (0.631–0.935)* 0.800 (0.642–
0.992)* 0.732 (0.556–0.962)* 
GA vs LA 803 (42.5) 572 (52.4) 0.769 (0.646–0.915)* 0.784 (0.654–0.941)* 0.659 (0.538–0.807)* 0.656 
(0.524–0.823)* 0.738 (0.555–0.983)* 
Death 
GA vs CS 406 (21.5) 236 (19.7) 1.009 (0.824–1.234) 0.944 (0.766–1.164) 1.052 (0.836–1.325) 0.902 (0.701–
1.162) 0.955 (0.699–1.304) 
GA vs LA 406 (21.5) 162 (14.8) 1.347 (1.075–1.686)* 1.301 (1.032–1.641)* 1.413 (1.095–1.823)* 1.331 
(1.005–1.762)* 1.220 (0.858–1.734) 
TICI 3 
GA vs CS 860 (43.1) 572 (44.9) 1.086 (0.932–1.264) 1.131 (0.962–1.331) 1.036 (0.868–1.237) 1.069 (0.879–
1.302) 1.180 (0.919–1.514) 
GA vs LA 860 (43.1) 448 (39.8) 0.893 (0.760–1.048) 0.867 (0.732–1.028) 0.806 (0.671–1.013) 0.784 (0.640–
1.018) 0.835 (0.642–1.087) 
TICI 2b/3 
GA vs CS 1509 (75.6) 934 (73.4) 1.136 (0.955–1.350) 1.210 (0.991–1.456) 1.120 (0.915–1.369) 1.102 (0.884–
1.374) 1.455 (0.903–1.936) 
GA vs LA 1509 (75.6) 883 (78.5) 0.884 (0.732–1.068) 0.843 (0.691–1.029) 0.825 (0.668–1.020) 0.804 (0.637–
1.015) 1.001 (0.738–1.358) 
Any ICH 
GA vs CS 398 (22.1) 341 (27.3) 0.714 (0.596–0.855)* 0.759 (0.630–0.914)* 0.803 (0.656–0.982)* 0.676 
(0.543–0.842)* 0.567 (0.431–0.746)* 
GA vs LA 398 (22.1) 328 (29.5) 0.638 (0.529–0.768)* 0.692 (0.572–0.836)* 0.748 (0.610–0.918)* 0.630 
(0.504–0.788)* 0.567 (0.427–0.753)* 
HI 
GA vs CS 210 (11.7) 180 (14.4) 0.778 (0.620–0.978)* 0.884 (0.669–1.065) 0.857 (0.672–1.092) 0.775 (0.598–
1.005) 0.691 (0.500–0.593)* 
GA vs LA 210 (11.7) 198 (17.8) 0.598 (0.477–0.750)* 0.659 (0.524–0.829)* 0.739 (0.580–0.941)* 0.669 
(0.515–0.869)* 0587 (0.422–0.816)* 
PH 
GA vs CS 162 (9) 157 (12.6) 0.643 (0.500–0.827)* 0.672 (0.520–0.869)* 0.699 (0.521–0.938)* 0.595 (0.435–
0.815)* 0.478 (0.324–0.707)* 
GA vs LA 162 (9) 125 (11.3) 0.735 (0.561–0.962)* 0.781 (0.594–1.026) 0.753 (0.554–1.022) 0.627 (0.452–
0.870)* 0.589 (0.388–0.895)* 
SAH 
GA vs CS 68 (3.8) 25 (2) 1.926 (0.993–3.170) 1.919 (0.899–3.209) 1.787 (0.907–3.097) 1.496 (0.833–2.686) 
1.277 (0.585–2.785) 
GA vs LA 68 (3.8) 29 (2.6) 1.553 (0.952–2.531) 1.459 (0.887–2.399) 1.440 (0.844–2.457) 1.292 (0.731–2.285) 
1.147 (0.553–2.379) 
sICH 
GA vs CS 37 (2.2) 26 (2.2) 1.235 (0.725–2.106) 1.193 (0.693–2.051) 1.570 (0.807–3.052) 1.501 (0.746–3.021) 
1.583 (0.696–3.598) 
GA vs LA 37 (2.2) 36 (3.3) 0.810 (0.490–1.340) 0.830 (0.497–1.387) 0.747 (0.426–1.307) 0.672 (0.373–1.209) 
0.715 (0.357–1.430) 
The model 1 included the following predefined variables: age, sex, intravenous thrombolysis, NIHSS score, 
and onset-to-groin time. The model 2 included variables 
of the model 1 plus LVO in the anterior circulation and procedure time. The model 3 included variables of 
the model 2 plus prestroke mRS score, antiplatelet, and oral 
anticoagulant. The model 4 included variables of the model 3 plus site occlusion, and ASPECTS. The model 5 
included variables of the model 4 plus type of procedure, 
additional intra-arterial fibrinolysis, and single thrombectomy device pass. ASPECTS indicates Alberta Stroke 
Program Early CT Score; CS, conscious sedation; GA, 
general anesthesia; HI, hemorrhagic infarct; ICH, intracerebral hemorrhage; LA, local anesthesia; LVO, large 
vessel occlusion; mRS, modified Rankin Scale; NIHSS, 
National Institutes of Health Stroke Scale; OR, odds ratio; PH, parenchymal hematoma; SAH, subarachnoid 
hemorrhage; sICH, symptomatic intracerebral hemorrhage; 
and TICI, Thrombolysis in Cerebral Infarction. 
*Statistical significance was established at 2-tailed 0.05 level (P<0.05). 
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for unbalanced variables and models of propensity score 
matching including predefined predictors; however, the 
rate of sICH was similar between the groups. One model 
of propensity score matching showed that the rate of 
death was higher in the GA group. After excluding 
patients who started GA during the procedure, results 
were unchanged. 
GA (versus CS) during mechanical thrombectomy 
was associated with lower rates of any ICH and PH 
after adjustment for unbalanced variables and predefined predictors; however, the rate of sICH was similar 
between the groups. Two models of adjustment for 
predefined variables showed that GA was associated 
also with a lower rate of HI, whereas 3 models showed 
that GA was associated also with a lower rate of favorable outcome. 
GA (versus LA) during mechanical thrombectomy 
was associated with lower rates of excellent and 
favorable outcome, any ICH, HI, and PH after adjustment for unbalanced variables and predefined 
predictors; however, the rate of sICH was similar between 
the groups. Four models of adjustment for predefined 
variables showed that GA was associated also with a 
higher rate of death. 
Our study showed that GA during thrombectomy was 
associated with worse functional outcomes, especially 
when compared with LA in line with 2 small studies14,15; 
however, the association was not related to an increase 
of sICH or to a decrease of recanalization success in 
the GA group. Further studies are needed to identify the 
underlying mechanisms, such as neurotoxicity according to type and duration of GA, hemodynamic adverse 
effects, hypocapnic conditions, or extracranial complications during GA, which could explain the association 
between GA and worse functional outcome. 
We are aware that our study has some limitations. 
First, the present study did not randomize patients by 
anesthesia type, but it is based on a retrospective analysis of prospectively collected data. Second, the 
number 
of missing data for outcome measures and predefined 
predictors might have influenced the final outcome. 
Third, reasons for the choice of GA (versus CS or LA) 
were not recorded; it is likely that these choices were 
influenced by unmeasurable factors related to individual physician’s decision, which might have influenced 
our key findings. Fourth, data on the type of anesthesia 
were not collected for the entire patient cohort. Fifth, 
data on duration of anesthetic exposure and intubation, 
type of anesthetic agent, and reasons of conversion 
from LA/CS to GA were not available. Finally, we did 
not use data of collateral circulation because they were 
missing in more than half of the patients included in 
the analyses, whereas data of other possible predictors 
such as the use of a balloon guide catheter were not 
systematically collected. 
Nevertheless, to the best of our knowledge, the present study included the largest cohort of patients 
treated 
with mechanical thrombectomy to assess whether there 
are differences of GA versus non-GA, GA versus CS, 
and GA versus LA on a complete panel of functional 
and radiological outcome measures after adjustment for 
unbalanced variables and models including predefined 
variables. 
CONCLUSIONS 
GA (versus non-GA) during mechanical thrombectomy 
was associated with worse functional outcomes. GA 
was associated with a lower rate of favorable outcome 
when compared with CS, whereas GA was associated 
with lower rates of excellent and favorable outcome 
and a higher rate of death when compared with LA. GA 
was associated with lower rates of intracerebral bleedings; however, the rate of sICH was similar among all 
the comparison groups. Recanalization success did not 
differ. Therefore, LA seems to be preferable to GA as 
anesthetic strategy during thrombectomy. However, the 
inclusion of an LA arm in future randomized clinical trials 
of anesthesia strategy is recommended. 
 
